Porwit-MacDonald A - Search Results

1

Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.

Knaust E, Porwit-MacDonald A, Gruber A, Xu D, Peterson C. Knaust E, et al. Leuk Res. 2003 Feb;27(2):183-91. doi: 10.1016/s0145-2126(02)00093-0. Leuk Res. 2003. PMID: 12526924

2

Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia.

Palucka KA, Knaust E, Xu D, Macnamara B, Porwit-Macdonald A, Gruber A, Peterson C, Björkholm M, Pisa P. Palucka KA, et al. Leuk Lymphoma. 1999 Jan;32(3-4):309-16. doi: 10.3109/10428199909167391. Leuk Lymphoma. 1999. PMID: 10037028

3

Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin.

Knaust E, Porwit-MacDonald A, Gruber A, Xu D, Peterson C. Knaust E, et al. Haematologica. 2000 Feb;85(2):124-32. Haematologica. 2000. PMID: 10681718

4

Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas.

MacNamara B, Wang W, Chen Z, Hou M, Mazur J, Gruber A, Porwit-MacDonald A. MacNamara B, et al. Haematologica. 2001 Apr;86(4):386-93. Haematologica. 2001. PMID: 11325644

5

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.

Andersson A, Ritz C, Lindgren D, Edén P, Lassen C, Heldrup J, Olofsson T, Råde J, Fontes M, Porwit-Macdonald A, Behrendtz M, Höglund M, Johansson B, Fioretos T. Andersson A, et al. Among authors: porwit macdonald a. Leukemia. 2007 Jun;21(6):1198-203. doi: 10.1038/sj.leu.2404688. Epub 2007 Apr 5. Leukemia. 2007. PMID: 17410184

6

Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.

Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G. Porwit-MacDonald A, et al. Leukemia. 1995 Jul;9(7):1191-8. Leukemia. 1995. PMID: 7543174

7

Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL.

Malec M, Björklund E, Söderhäll S, Mazur J, Sjögren AM, Pisa P, Björkholm M, Porwit-MacDonald A. Malec M, et al. Leukemia. 2001 May;15(5):716-27. doi: 10.1038/sj.leu.2402091. Leukemia. 2001. PMID: 11368431

8

Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.

Björklund E, Mazur J, Söderhäll S, Porwit-MacDonald A. Björklund E, et al. Leukemia. 2003 Jan;17(1):138-48. doi: 10.1038/sj.leu.2402736. Leukemia. 2003. PMID: 12529671

9

Balance between proliferation and apoptosis in leukemic cell lines resistant to cytostatics.

Macnamara B, Palucka KA, Porwit-MacDonald A. Macnamara B, et al. Leuk Lymphoma. 1999 Dec;36(1-2):179-89. doi: 10.3109/10428199909145962. Leuk Lymphoma. 1999. PMID: 10613463

10

BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).

Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A. Porwit-MacDonald A, et al. Leukemia. 2000 May;14(5):816-25. doi: 10.1038/sj.leu.2401741. Leukemia. 2000. PMID: 10803512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters